When: February 3rd, 2021
Where: Anywhere you are!
- Simon Barnett (Genomics Analyst, ARK Invest)
Lisa Lake Langley, CEO & President, Emerge Canada Inc. sat down with Simon Barnett (Genomics Analyst, ARK Invest) to discuss the developments in genomics.
Here are some of the questions asked:
- As costs come down, do you see this technology replacing the single cancer screening methods and/or increasing the number of cancer screenings?
- Are there any genomic advancements in cardiac disease?
- How big is the optical mapping market for companies in this area?